Dr. Christopher Larsen, MD

NPI: 1447434840
Total Payments
$28,514
2024 Payments
$11,986
Companies
7
Transactions
14
Medicare Patients
3,928
Medicare Billing
$256,685

Payment Breakdown by Category

Consulting$25,971 (91.1%)
Travel$1,582 (5.5%)
Food & Beverage$960.53 (3.4%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $25,971 4 91.1%
Travel and Lodging $1,582 3 5.5%
Food and Beverage $960.53 7 3.4%

Top Paying Companies

Company Total Records Latest Year
GENZYME CORPORATION $11,696 1 $0 (2018)
Novartis Pharmaceuticals Corporation $6,353 6 $0 (2024)
CALLIDITAS THERAPEUTICS US INC. $5,634 3 $0 (2024)
AstraZeneca UK Limited $4,750 1 $0 (2020)
Aerie Pharmaceuticals, Inc. $37.35 1 $0 (2018)
Alexion Pharmaceuticals, Inc. $31.37 1 $0 (2017)
Zimmer Biomet Holdings, Inc. $12.83 1 $0 (2018)

Payment History by Year

Year Amount Transactions Top Company
2024 $11,986 9 Novartis Pharmaceuticals Corporation ($6,353)
2020 $4,750 1 AstraZeneca UK Limited ($4,750)
2018 $11,746 3 GENZYME CORPORATION ($11,696)
2017 $31.37 1 Alexion Pharmaceuticals, Inc. ($31.37)

All Payment Transactions

14 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
11/08/2024 Novartis Pharmaceuticals Corporation Consulting Fee Cash or cash equivalent $5,025.00 General
11/08/2024 Novartis Pharmaceuticals Corporation Travel and Lodging In-kind items and services $601.41 General
11/08/2024 Novartis Pharmaceuticals Corporation Food and Beverage In-kind items and services $290.75 General
11/08/2024 Novartis Pharmaceuticals Corporation Travel and Lodging In-kind items and services $207.28 General
11/07/2024 Novartis Pharmaceuticals Corporation Food and Beverage In-kind items and services $139.99 General
10/15/2024 CALLIDITAS THERAPEUTICS US INC. TARPEYO (Drug) Consulting Fee Cash or cash equivalent $4,500.00 General
Category: Nephrology
09/27/2024 CALLIDITAS THERAPEUTICS US INC. TARPEYO (Drug) Travel and Lodging Cash or cash equivalent $773.54 General
Category: Nephrology
09/27/2024 CALLIDITAS THERAPEUTICS US INC. TARPEYO (Drug) Food and Beverage In-kind items and services $360.00 General
Category: Nephrology
08/20/2024 Novartis Pharmaceuticals Corporation Food and Beverage In-kind items and services $88.24 General
08/21/2020 AstraZeneca UK Limited Consulting Fee Cash or cash equivalent $4,750.00 General
08/29/2018 Aerie Pharmaceuticals, Inc. Rhopressa (Drug) Food and Beverage In-kind items and services $37.35 General
Category: Ophthalmology
08/02/2018 GENZYME CORPORATION FABRAZYME (Drug) Consulting Fee Cash or cash equivalent $11,696.00 General
Category: RARE DISEASE GENETICS
01/05/2018 Zimmer Biomet Holdings, Inc. Eztetic (Device) Food and Beverage In-kind items and services $12.83 General
Category: Dental
03/05/2017 Alexion Pharmaceuticals, Inc. SOLIRIS (Drug) Food and Beverage In-kind items and services $31.37 General
Category: Immunology

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 7 409 1,259 $73,697 $25,339
2022 7 776 2,415 $142,612 $50,266
2021 7 1,319 4,243 $239,105 $86,220
2020 7 1,424 4,480 $253,817 $94,860
Total Patients
3,928
Total Services
12,397
Medicare Billing
$256,685
Procedure Codes
28

All Medicare Procedures & Services

28 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
88350 Antibody evaluation, each additional single antibody stain procedure Facility 2023 77 628 $47,037 $13,343 28.4%
88348 Electron microscopy for diagnosis Facility 2023 64 64 $6,858 $3,614 52.7%
88313 Special stained specimen slides to examine tissue including interpretation and report Facility 2023 77 371 $7,227 $3,254 45.0%
88305 Pathology examination of tissue using a microscope, intermediate complexity Facility 2023 78 78 $4,735 $2,129 45.0%
88346 Antibody evaluation, initial single antibody stain procedure Facility 2023 77 77 $5,767 $2,030 35.2%
88342 Special stained specimen slides to examine tissue, initial procedure Facility 2023 25 25 $1,264 $638.25 50.5%
88341 Special stained specimen slides to examine tissue, each additional procedure Facility 2023 11 16 $809.12 $330.83 40.9%
88350 Antibody evaluation, each additional single antibody stain procedure Facility 2022 145 1,215 $91,004 $26,450 29.1%
88348 Electron microscopy for diagnosis Facility 2022 127 130 $13,930 $7,473 53.7%
88313 Special stained specimen slides to examine tissue including interpretation and report Facility 2022 143 693 $13,500 $6,220 46.1%
88305 Pathology examination of tissue using a microscope, intermediate complexity Facility 2022 144 147 $8,923 $4,105 46.0%
88346 Antibody evaluation, initial single antibody stain procedure Facility 2022 146 149 $11,160 $4,018 36.0%
88342 Special stained specimen slides to examine tissue, initial procedure Facility 2022 55 59 $2,984 $1,536 51.5%
88341 Special stained specimen slides to examine tissue, each additional procedure Facility 2022 16 22 $1,113 $463.91 41.7%
88350 Antibody evaluation, each additional single antibody stain procedure Facility 2021 247 1,983 $148,527 $43,871 29.5%
88313 Special stained specimen slides to examine tissue including interpretation and report Facility 2021 250 1,425 $27,759 $12,930 46.6%
88348 Electron microscopy for diagnosis Facility 2021 213 213 $22,823 $12,474 54.7%
88305 Pathology examination of tissue using a microscope, intermediate complexity Facility 2021 250 250 $15,175 $7,057 46.5%
88346 Antibody evaluation, initial single antibody stain procedure Facility 2021 247 247 $18,500 $6,759 36.5%
88342 Special stained specimen slides to examine tissue, initial procedure Facility 2021 91 91 $4,602 $2,391 52.0%
88341 Special stained specimen slides to examine tissue, each additional procedure Facility 2021 21 34 $1,719 $736.82 42.9%
88350 Antibody evaluation Facility 2020 261 2,077 $155,567 $47,681 30.6%
88348 Electron microscopy for diagnosis Facility 2020 231 232 $25,410 $13,986 55.0%
88313 Special stained specimen slides to examine tissue including interpretation and report Facility 2020 265 1,483 $28,889 $13,863 48.0%
88305 Pathology examination of tissue using a microscope, intermediate complexity Facility 2020 264 266 $16,146 $7,785 48.2%

About Dr. Christopher Larsen, MD

Dr. Christopher Larsen, MD is a Anatomic Pathology healthcare provider based in Little Rock, Arkansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/20/2007. The National Provider Identifier (NPI) number assigned to this provider is 1447434840.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Larsen, MD has received a total of $28,514 in payments from pharmaceutical and medical device companies, with $11,986 received in 2024. These payments were reported across 14 transactions from 7 companies. The most common payment nature is "Consulting Fee" ($25,971).

As a Medicare-enrolled provider, Larsen has provided services to 3,928 Medicare beneficiaries, totaling 12,397 services with total Medicare billing of $256,685. Data is available for 4 years (2020–2023), covering 28 distinct procedure/service records.

Practice Information

  • Specialty Anatomic Pathology
  • Location Little Rock, AR
  • Active Since 12/20/2007
  • Last Updated 04/07/2021
  • Taxonomy Code 207ZP0101X
  • Entity Type Individual
  • NPI Number 1447434840

Products in Payments

  • FABRAZYME (Drug) $11,696
  • TARPEYO (Drug) $5,634
  • Rhopressa (Drug) $37.35
  • SOLIRIS (Drug) $31.37
  • Eztetic (Device) $12.83

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Anatomic Pathology Doctors in Little Rock